M. Spaanderman - Concepedia

Author

M. Spaanderman

Also Known As

J Rischen‐Vos, M E A Spaanderman, M. E. A. Spaanderman, M. E. Spaanderman, M. Spaanderman, M.E. Spaanderman, M.E.A. Spaanderman, MEA Spaanderman

Publications

851

Citations

H-Index

Concepts

All Affiliations

Maastricht University Medical Centre Maastricht University Radboud University Nijmegen Radboud University Medical Center Amsterdam UMC Location Vrije Universiteit Amsterdam

About

M. Spaanderman is an author at Maastricht University Medical Centre specializing in medicine, obstetrics, and maternal health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	185
2	Public Health	3	3	42
3	Critical Care Medicine	2	2	32
4	Emergency Medicine	2	2	32
5	Engineering	1	1	31

M. Spaanderman

Publications

554

Citations

H-Index

Page 1

	Year	Citations
Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? Tamara Stampalija, Birgit Arabin, Hans Wolf, American Journal of Obstetrics and Gynecology NeonatologyFetal MedicinePediatricsMaternal HealthBrain Injury	2017	91
Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women NM Breetveld, Chahinda Ghossein‐Doha, Sander M. J. van Kuijk, BJOG An International Journal of Obstetrics & Gynaecology	2014	60
Metabolic syndrome after pregnancies complicated by pre‐eclampsia or small‐for‐gestational‐age: a retrospective cohort Salwan Al‐Nasiry, Chahinda Ghossein‐Doha, SEJ Polman, BJOG An International Journal of Obstetrics & Gynaecology	2014	42
Metabolic syndrome and the risk for recurrent pre‐eclampsia: a retrospective cohort study Eva Stekkinger, MJ van der Vlugt, Arie P.J. van Dijk, BJOG An International Journal of Obstetrics & Gynaecology	2013	36
Maternal cardiac adaptation to subsequent pregnancy in formerly pre‐eclamptic women according to recurrence of pre‐eclampsia Chahinda Ghossein‐Doha, M. Spaanderman, R. Al Doulah, Ultrasound in Obstetrics and Gynecology	2015	34
Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight M. Hendrix, J. Bons, Nicole O Alers, Placenta	2019	33
A new method for plasma volume measurements with unlabeled dextran-70 instead of 125I-labeled albumin as an indicator B.K. van Kreel, Erik van Beek, M. Spaanderman, Clinica Chimica Acta Plasma Volume MeasurementsEngineeringAnalytical InstrumentationMeasurementMedicine	1998	31
Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment? Jakoba J Kalk, Anjoke Huisjes, Christianne J.M. de Groot, PubMed	2004	29
Reduced fetal growth velocities and the association with neonatal outcomes in appropriate-for-gestational-age neonates: a retrospective cohort study M. Hendrix, Sander M. J. van Kuijk, Antonio W. D. Gavilanes, BMC Pregnancy and Childbirth	2019	27
Unexplained first trimester recurrent pregnancy loss and low venous reserves J. Donckers, Ralph R. Scholten, Wim J.G. Oyen, Human Reproduction	2012	22

Page 1